Lan-Zhen Wang
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
-
- DNA Repair Mechanisms
- Cancer therapeutics and mechanisms
Papers in
-
- DNA Repair Mechanisms 4
- Cancer therapeutics and mechanisms 3
- Biochemical and Molecular Research 3
- Ubiquitin and proteasome pathways 2
- Oncology 13
- Cancer-related Molecular Pathways 8
- PARP inhibition in cancer therapy 4
- Co-authors
- David R. Newell (11 shared papers)Nicola J. Curtin (9 shared papers)Zdeněk Hostomský (4 shared papers)Suzanne Kyle (4 shared papers)Jane Endicott (5 shared papers)M.E.M. Noble (5 shared papers)Stephen E. Webber (3 shared papers)Huw D. Thomas (6 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Cell Cycle (2 papers)Journal of Medicinal Chemistry (2 papers)British Journal of Cancer (1 paper)Journal of the American Chemical Society (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Lan-Zhen Wang
16 papers receiving 888 citations
Peers
Comparison fields: 5 of 74
- Oncology 520
- Molecular Biology 553
- Genetics 71
- Organic Chemistry 172
- Computational Theory and Mathematics 87
Countries citing papers authored by Lan-Zhen Wang
This map shows the geographic impact of Lan-Zhen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan-Zhen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan-Zhen Wang more than expected).
Fields of papers citing papers by Lan-Zhen Wang
This network shows the impact of papers produced by Lan-Zhen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan-Zhen Wang. The network helps show where Lan-Zhen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan-Zhen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 233 | |
| 2 | 2004 | 120 | |
| 3 | 2018 | 106 | |
| 4 | 2004 | 105 | |
| 5 | 2006 | 65 | |
| 6 | Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies. | 2003 | 64 |
| 7 | 2016 | 45 | |
| 8 | 2004 | 33 | |
| 9 | 2012 | 27 | |
| 10 | 2016 | 22 | |
| 11 | 2021 | 16 | |
| 12 | 2008 | 15 | |
| 13 | 2010 | 14 | |
| 14 | 2013 | 13 | |
| 15 | 2011 | 13 | |
| 16 | 2009 | 8 |
About Lan-Zhen Wang
Lan-Zhen Wang is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Infectious Diseases and Cell Biology, having authored 16 papers that have together received 899 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (4 papers), PARP inhibition in cancer therapy (4 papers), Cancer therapeutics and mechanisms (3 papers), Biochemical and Molecular Research (3 papers), Synthesis and Catalytic Reactions (2 papers), HIV/AIDS drug development and treatment (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Oncology (520 citations), Molecular Biology (553 citations), Genetics (71 citations), Organic Chemistry (172 citations) and Computational Theory and Mathematics (87 citations). Lan-Zhen Wang has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include David R. Newell, Nicola J. Curtin, Zdeněk Hostomský, Suzanne Kyle, Jane Endicott, M.E.M. Noble, Stephen E. Webber, Huw D. Thomas, Karen A. Maegley and Roger J. Griffin. Their work appears in journals such as Molecular Cancer Therapeutics, Cell Cycle, Journal of Medicinal Chemistry, British Journal of Cancer and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.